SECURE POINT TECHNOLOGIES INC - FORM 8-K

Attached files

file	filename
EX-99.2 - EXHIBIT 99.2 - SECURE POINT TECHNOLOGIES INC	imsc131028_ex99z2.htm
EX-99.1 - EXHIBIT 99.1 - SECURE POINT TECHNOLOGIES INC	imsc131028_ex99z1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 28, 2013

IMPLANT SCIENCES CORPORATION

(Exact name of Registrant as Specified in its Charter)

MASSACHUSETTS

(State or Other Jurisdiction of Incorporation)


001-14949		04-2837126
(Commission File Number)		(I.R.S. Employer Identification Number)

500 Research Drive

Unit 3

Wilmington, Massachusetts 01887

(Address of Principal Executive Offices, including Zip Code)

(978) 752-1700

(Registrant’s Telephone Number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

□

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01.

Regulation FD Disclosure

On October 28, 2013, the Company issued a press release announcing the acceptance of the Company’s QS-B220 explosives trace detector onto the “Qualified” section of the Transportation Security Administration’s Air Cargo Screening Technology List. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference. The letter from the Transportation Security Administration notifying the Company of its decision is attached hereto as Exhibit 99.2 and is incorporated herein by this reference.

The information set forth in this Item 7.01 and exhibits 99.1 and 99.2 to this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits

Exhibit No.

Description

99.1

Press Release of Implant Science Corporation, dated October 28, 2013

99.2

Letter dated October 18, 2013 from the Transportation Security Administration

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IMPLANT SCIENCES CORPORATION

By: /s/ Roger P. Deschenes

Roger P. Deschenes

Vice President, Finance and Chief Financial Officer

Date: October 28, 2013

EXHIBIT INDEX